696601-20-4 Usage
Description
(S)-1-[(R)-2-Methoxy-1-(4-trifluoromethyl-phenyl)-ethyl]-2-methyl-4-(4-methyl-piperidin-4-yl)-piperazine is a complex organic molecule characterized by its multiple functional groups and stereochemistry. It features a piperazine ring with a 4-methyl-piperidin-4-yl substituent and a trifluoromethyl-phenyl-ethyl substituent, along with a methoxy and methyl substituent. The (S) and (R) prefixes denote the stereochemistry at specific chiral centers, which may contribute to its potential pharmaceutical applications.
Uses
Used in Pharmaceutical Applications:
(S)-1-[(R)-2-Methoxy-1-(4-trifluoromethyl-phenyl)-ethyl]-2-methyl-4-(4-methyl-piperidin-4-yl)-piperazine is used as a potential pharmaceutical compound for its complex structure and multiple functional groups. The specific application reason is that its unique configuration and functional groups may allow it to interact with biological targets in ways that could be beneficial for therapeutic purposes. However, further research is necessary to fully understand its properties and potential uses.
Used in Research and Development:
In the field of chemical research and development, (S)-1-[(R)-2-Methoxy-1-(4-trifluoromethyl-phenyl)-ethyl]-2-methyl-4-(4-methyl-piperidin-4-yl)-piperazine serves as a subject for studying the effects of stereochemistry and functional group interactions on molecular properties and biological activities. The application reason is to advance the understanding of complex molecular structures and their implications in drug design and development.
Check Digit Verification of cas no
The CAS Registry Mumber 696601-20-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,9,6,6,0 and 1 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 696601-20:
(8*6)+(7*9)+(6*6)+(5*6)+(4*0)+(3*1)+(2*2)+(1*0)=184
184 % 10 = 4
So 696601-20-4 is a valid CAS Registry Number.
InChI:InChI=1S/C21H32F3N3O/c1-16-14-26(20(2)8-10-25-11-9-20)12-13-27(16)19(15-28-3)17-4-6-18(7-5-17)21(22,23)24/h4-7,16,19,25H,8-15H2,1-3H3/t16-,19-/m0/s1
696601-20-4Relevant articles and documents
Forward- and reverse-synthesis of piperazinopiperidine amide analogs: A general access to structurally diverse 4-piperazinopiperidine-based CCR5 antagonists
Feng, Dong-Zhi,Song, Yan-Li,Jiang, Xiao-Hua,Chen, Li,Long, Ya-Qiu
, p. 2690 - 2697 (2008/03/12)
Piperazinopiperidine amide analogs are among the most promising CCR5 antagonists. As an effective extension of a previously-reported methodology to synthesize such compounds, forward- and reverse-syntheses were successfully developed in which the convergent synthesis of the piperazinopiperidine nucleus, with a building block of 4-substituent-4-aminopiperidine, served as a common key step. The two-way approach affords a comprehensive access to the piperazinopiperidine templated library with variation on the pharmacophore sites. Thus, a SAR study of our synthesized piperazinopiperidine-based CCR5 antagonists was conducted with respect to the structure and configuration of the substituent on the piperazine ring. The S-configuration of the benzylic-substituent is vital for the CCR5 binding, and the bulky or aryl substituent on the 2-position in the piperazine ring is detrimental to the activity. By using the forward-synthesis approach, the best compound in the chiral piperazine-based CCR5 antagonist series, Sch-D (Vicriviroc), was conveniently synthesized in an excellent yield. The Royal Society of Chemistry.
Piperazine derivatives useful as CCR5 antagonists
-
Page column 115, (2010/02/05)
The use of CCR5 antagonists of the formula or a pharmaceutically acceptable salt thereof, wherein R is optionally substituted phenyl, pyridyl, thiophenyl or naphthyl; R1is hydrogen or alkyl; R2is substituted phenyl, substituted heter
